Pneumonia Testing Market to Hit US$ 1,092.4 Million by 2031, Says Growth Plus Reports
Growth Plus Reports
6 min read
Growth Plus Reports
Newark, New Castle, USA, July 04, 2023 (GLOBE NEWSWIRE) -- According to the latest analysis by Growth Plus Reports, the global pneumonia testing market was estimated to be valued at US$ 635.7 million in 2022. It is anticipated to witness a notable growth trajectory, with a projected revenue CAGR of 6.2%. By the year 2031, the market is poised to surpass the US$ 1,092.4 million mark.
The global market for pneumonia testing was analyzed, and it is expected to rise significantly during the forecast period. An examination for pneumonia, a lung infection that causes inflammation of the lungs, is referred to as pneumonia testing.
Type, Test Type, Method, Technology, End User, and Region
Regional Scope
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Key Takeaways:
The rising prevalence of pneumonia is driving the market revenue share.
The high sensitivity and reliability of these devices are boosting the demand for the products.
Advancements in technology and rising R&D activity are creating a strong product pipeline.
Recent Development in the Global Pneumonia Testing Market:
In September 2021, To identify the main pathogens linked to atypical pneumonia, CerTest Biotec developed and validated its CE-IVD multiplex test VIASURE C. pneumoniae, M. pneumoniae, and L. pneumophila real-time PCR kit.
Competitive Landscape
Following is a list of the top market players operating in the global market for pneumonia testing:
Becton, Dickinson, and Company
Meridian Bioscience Inc
Qiagen N.V.
Thermo Fisher Scientific Inc.
Alere Inc.
Quidel Corporation
Market Drivers and Restraints:
Increased acceptance of point of care (POC) testing and advancements in the field of nucleic acid detection globally are the major factors influencing the revenue growth of the global market for pneumonia testing. The rise in the elderly population, the explosion in diagnostic advancements for pneumonia, and the incidence of pneumonia in children around the world all contribute to the market revenue expansion.
However, due to reliability concerns, diagnostic centers and hospitals still prefer the traditional method, which is expected to restrain the revenue growth of the global pneumonia testing market.
Based on platform type, the global pneumonia testing market is segmented into bacterial, viral, and others. Due to the high infection rates of Streptococcus pneumoniae easy detection methods, the bacterial segment accounts for the largest market revenue share. The bacterial segment is further sub-segmented into Streptococcus, Legionella, Chlamydophila, and Mycoplasma.
Segmentation By Test Type
Based on the test type, the global pneumonia testing market is segmented into blood tests, sputum tests, urine tests, and others. The blood test segment accounts for the largest revenue share due to the precise results.
Segmentation By Method
Based on the method, the global pneumonia testing market is segmented into immunodiagnostic, molecular diagnostic, and point-of-care (POC) testing. The point-of-care (POC) testing segment accounts for the largest revenue share due to quick and accurate results with the requirement of a small amount sample.
Segmentation By Technology
Based on the technology, the global pneumonia testing market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, immunohistochemistry (IHC), polymerase chain reaction (PCR), and others. The enzyme-linked immunosorbent assay (ELISA) segment accounts for the largest revenue share due to its excellent sensitivity and specificity, requirement small amount of sample, and affordability.
Segmentation By End User
Based on the end user, the global pneumonia testing market is segmented into hospitals, diagnostic centers, and others. The hospital segment accounts for the largest revenue share due to the large number of patients, advanced healthcare infrastructure, and need for precise results for quick treatment.
Regional Growth Dynamics
Based on the region, the global pneumonia testing market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to the high prevalence of pneumonia, high demand for precision diagnostics, and cutting-edge lab facilities, North America accounts for the largest revenue share in the global market.
Report Coverage
Growth Plus Reports studied the global market for pneumonia testing in-depth. Basic market features, important investment sectors, analyses of regional growth, revenue projections, rival market participants, and mergers and acquisitions were all examined.
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2021
Base Year – 2022
Forecast Years – 2023 to 2031
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecast Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2022)
Regulatory Landscape
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL PNEUMONIA TESTING MARKET - ANALYSIS & FORECAST, BY TYPE
Bacterial
Streptococcus
Legionella
Chlamydophila
Mycoplasma
Viral
Others
GLOBAL PNEUMONIA TESTING MARKET - ANALYSIS & FORECAST, BY TEST TYPE
Blood Test
Sputum Test
Urine Test
Others
GLOBAL PNEUMONIA TESTING MARKET - ANALYSIS & FORECAST, BY METHOD
Combination Antihypertensives Market by Type (ACE Inhibitors with Calcium Channel blocking agents, ACE inhibitors with thiazides), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Hydatid Disease Treatment Market by Drug (Mebendazole, Albendazole), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
High-Grade Neuroendocrine Neoplasms Market by Drug Class (Platinum Coordination Complexes, Somatostatin Analogues), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Postoperative Pain Medication Market by Drug Class (NSAIDS, Opioids), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Mast Cell Stabilizers Market by Type (Mastocytosis, Seasonal Allergic Rhinitis, and Perennial Allergic Conjunctivitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook and Forecast 2023-2031
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
